Jeffrey D Marrazzo's Net Worth
$59.8 Million
Who is Jeffrey D Marrazzo?
Jeffrey D Marrazzo has an estimated net worth of $59.8 Million. This is based on reported shares across multiple companies, which include Spark Therapeutics, Inc., and Prime Medicine, Inc..
SEC CIK
Jeffrey D Marrazzo's CIK is 0001631262
Past Insider Trading and Trends
2016 was Jeffrey D Marrazzo's most active year for acquiring shares with 14 total transactions. Jeffrey D Marrazzo's most active month to acquire stocks was the month of December. 2016 was Jeffrey D Marrazzo's most active year for disposing of shares, totalling 38 transactions. Jeffrey D Marrazzo's most active month to dispose stocks was the month of July. 2017 saw Jeffrey D Marrazzo paying a total of $552,000.00 for 250,000 shares, this is the most they've acquired in one year. In 2019 Jeffrey D Marrazzo cashed out on 1,072,615 shares for a total of $40,799,648.82, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Spark Therapeutics, Inc. No price found
CHIEF EXECUTIVE OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -355.21K |
$114.50 | -$40,672,117.50 |
0
|
Dec 17
| |||
Form 4
| +16.36% | 49.94K |
$3.45 | $172,293.00 | 355.21K |
Mar 15
| |||
Form 4
| +1.98% | 5.92K |
$45.08 | -$127,531.32 | 305.27K |
Jan 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 15
| |||
Form 4
| +2.05% | 6K |
$3.45 | $20,700.00 | 299.35K |
Dec 28
| |||
Form 4
| +1.16% | 3.35K |
$50.55 | -$83,205.30 | 293.35K |
Jan 18
| |||
Form 4
| +26.09% | 60K |
$3.45 | $207,000.00 | 290K |
Dec 19
| |||
Form 4
|
—
|
0
|
$37.50 | -$1,361,800.00 | 230K |
Scheduled
|
Nov 13
| ||
Form 4
|
—
|
0
|
$41.73 | -$1,634,556.00 | 230K |
Scheduled
|
Aug 23
| ||
Form 4
|
—
|
0
|
$39.28 | -$1,074,750.00 | 230K |
Scheduled
|
Aug 11
| ||
Form 4
|
—
|
0
|
$41.73 | -$2,193,444.00 | 230K |
Scheduled
|
Aug 2
| ||
Form 4
|
—
|
0
|
$34.23 | -$348,926.95 | 230K |
Scheduled
|
Jul 5
| ||
Form 4
|
—
|
0
|
$34.23 | -$574,323.05 | 230K |
Scheduled
|
Jun 20 - Jun 21
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 4
|
—
|
0
|
$29.06 | -$256,056.00 | 230K |
Scheduled
|
Oct 17
| ||
Form 4
|
—
|
0
|
$33.07 | -$592,334.88 | 230K |
Scheduled
|
Sep 16
| ||
Form 4
|
—
|
0
|
$33.10 | -$592,888.00 | 230K |
Scheduled
|
Aug 15
| ||
Form 4
|
—
|
0
|
$31.75 | -$960,392.86 | 230K |
Scheduled
|
Aug 10 - Aug 11
| ||
Form 4
|
—
|
0
|
$31.85 | -$51,111.00 | 230K |
Scheduled
|
Aug 4 - Aug 8
| ||
Form 4
|
—
|
0
|
$31.74 | -$935,141.94 | 230K |
Scheduled
|
Aug 1 - Aug 3
| ||
Form 4
|
—
|
0
|
$27.99 | -$245,400.00 | 230K |
Scheduled
|
Jul 18
| ||
Form 4
|
—
|
0
|
$24.97 | -$215,201.00 | 230K |
Scheduled
|
Jun 15
| ||
Form 4
|
—
|
0
|
$31.73 | -$33,930.00 | 230K |
Scheduled
|
May 31
| ||
Form 4
|
—
|
0
|
$24.73 | -$1,064,008.50 | 230K |
Scheduled
|
May 19
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
| -24.59% | -75.00K |
$48.35 | -$3,625,892.95 | 230K |
Oct 12
| |||
Form 4
| -19.74% | -75.00K |
$47.82 | -$3,586,427.45 | 305K |
Oct 7 - Oct 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Prime Medicine, Inc. (PRME) Snapshot price: $6.74
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||